Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery
暂无分享,去创建一个
P. Jänne | D. Sugarbaker | R. Bueno | E. Baldini | M. Othus | A. Allen | M. Rabin | S. Mentzer | H. Çağlar | B. Johnson
[1] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[2] W. Curran,et al. Concomitant Radio-chemotherapy (CT-RT) versus Sequential CT-RT In Locally Advanced Non-Small-Cell Lung Cancer (NSCLC): A Meta-Analysis Using Individual Patient Data (IPD) From Randomised Clinical Trials (RCTs) , 2007 .
[3] R. Govindan,et al. Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] A. Bezjak,et al. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer. , 2007, The Journal of thoracic and cardiovascular surgery.
[5] Joe Y. Chang,et al. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone. , 2007, International journal of radiation oncology, biology, physics.
[6] Benjamin Movsas,et al. Randomized trial of amifostine in locally advanced non-small cell lung cancer (NSCLC) patients receiving chemotherapy and hyperfractionated radiation (HRT): Long-term survival results of Radiation Therapy Oncology Group (RTOG) 9801 , 2007 .
[7] J. Herndon,et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] K. Kelly,et al. Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504). , 2006, Clinical lung cancer.
[9] M. Ohta,et al. Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[10] R. Shemin,et al. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. , 2006, The Annals of thoracic surgery.
[11] J. Jett,et al. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. , 2005, International journal of radiation oncology, biology, physics.
[12] R. T. Ten Haken,et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. , 2005, International journal of radiation oncology, biology, physics.
[13] Walter J Curran,et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] J. Daurès,et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Michael R. Green,et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309) , 2005 .
[16] D. Ettinger,et al. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? , 2005, Lung cancer.
[17] P. Jänne,et al. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] C. Ling,et al. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.
[19] M. Suntharalingam,et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. , 2004, The Annals of thoracic surgery.
[20] M. Socinski,et al. Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] B. Jeremic. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)? , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] Di Yan,et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. , 2003, International journal of radiation oncology, biology, physics.
[23] R. Livingston,et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] M. Socinski,et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. , 2002, International journal of radiation oncology, biology, physics.
[25] J. Crowley,et al. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] M. Socinski,et al. Dose‐escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma , 2001, Cancer.
[27] W. Richards,et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. , 2000, The Annals of thoracic surgery.
[28] W. Curran,et al. Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410 , 2000 .
[29] J. Pignon,et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] H. Choy,et al. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] M. Kerin. Cancer principles and practice of oncology , 1997 .
[32] D. Sugarbaker,et al. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC). , 1997, Lung cancer.
[33] J. Crowley,et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] V. Rusch. Adjuvant and neoadjuvant therapy for stages I through III non-small cell lung cancer. , 1994, The Annals of thoracic surgery.
[35] J. Crowley,et al. Neoadjuvant therapy: A novel and effective treatment for stage IIIb non-small cell lung cancer , 1994 .
[36] C. Coltman. Southwest oncology group , 1990, Cancer.
[37] D. Choy,et al. A randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung. , 1988, International journal of radiation oncology, biology, physics.
[38] R. Komaki,et al. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. , 1998, International journal of radiation oncology, biology, physics.
[39] M. Saunders,et al. The long-term outcome after radical radiotherapy for advanced localized non-small cell carcinoma of the lung. , 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).
[40] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.